First Time Loading...

Guardion Health Sciences Inc
NASDAQ:GHSI

Watchlist Manager
Guardion Health Sciences Inc Logo
Guardion Health Sciences Inc
NASDAQ:GHSI
Watchlist
Price: 7.98 USD -3.62% Market Closed
Updated: Apr 25, 2024
Section:
 

Wall Street
Price Targets

GHSI Price Targets Summary
Guardion Health Sciences Inc

Wall Street analysts forecast GHSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GHSI is 40.8 USD with a low forecast of 40.4 USD and a high forecast of 42 USD.

GHSI Lowest Forecast
Wall Street Target
40.4 USD
406% Upside
GHSI Average Forecast
Wall Street Target
40.8 USD
411% Upside
GHSI Highest Forecast
Wall Street Target
42 USD
426% Upside
Lowest
Price Target
40.4 USD
406% Upside
Average
Price Target
40.8 USD
411% Upside
Highest
Price Target
42 USD
426% Upside
Guardion Health Sciences Inc Competitors:
Price Targets
973
L'Occitane International SA
1% Upside
ICOS
Intercos SpA
37% Upside
COTY
Coty Inc
19% Upside
BAJAJCON
Bajaj Consumer Care Ltd
15% Upside
973
L'Occitane International SA
1% Upside
ICOS
Intercos SpA
37% Upside
COTY
Coty Inc
19% Upside
BAJAJCON
Bajaj Consumer Care Ltd
15% Upside
300791
Sirio Pharma Co Ltd
4% Downside
N
194700
Novarex Co Ltd
84% Upside
4190
Jourdeness Group Ltd
169% Upside
6630
Ya-Man Ltd
5% Downside

Revenue
Forecast

Revenue Estimate
Guardion Health Sciences Inc

For the last 8 years the compound annual growth rate for Guardion Health Sciences Inc's revenue is 80%. The projected CAGR for the next 2 years is 11%.

80%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Guardion Health Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Guardion Health Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
GHSI intrinsic value, competitors valuation, and company profile.
DCF Valuation
GHSI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GHSI stock valuation using valuation multiples.
Wall Street Estimates
GHSI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GHSI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GHSI's stock price target?
Price Target
40.8 USD

According to Wall Street analysts, the average 1-year price target for GHSI is 40.8 USD with a low forecast of 40.4 USD and a high forecast of 42 USD.

What is Guardion Health Sciences Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Guardion Health Sciences Inc's revenue is 80%. The projected CAGR for the next 2 years is 11%.

ALPHA SPREAD
Join more than 131,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.